Clinical Evaluation Report (CER) for Medical Devices: EU MDR Compliance Guide
A Clinical Evaluation Report (CER) is a mandatory regulatory document that compiles and analyzes clinical data to demonstrate the safety, performance, and clinical benefit of a medical device. Under the European Union Medical Device Regulation (EU MDR 2017/745), establishing a robust CER is a prerequisite for achieving and maintaining CE Marking for all device risk classes.
Whether introducing a novel technology or maintaining legacy products, manufacturers must compile clinical evidence showing their device achieves its intended purpose without posing unacceptable risks to patients or users.
Regulatory Excellence for Global Medical Device Markets
The Regulatory Framework: EU MDR Article 61 & MEDDEV 2.7/1 Rev 4
Under EU MDR 2017/745, clinical evaluation is governed primarily by Article 61 and Annex XIV (Part A). To ensure conformity during Notified Body audits, manufacturers rely on the guidance document MEDDEV 2.7/1 Rev. 4, which outlines the methodology for clinical data collection, appraisal, and analysis.
| EU MDR Article 61 Framework | Details |
| Clinical Evaluation Plan (CEP) | Defines scope, clinical indicators, and evaluation methodologies. |
| Technical File Integration (GSPR) | Validates compliance with General Safety & Performance Requirements (Annex I). |
| Continuous Lifecycle Maintenance | Feeds Post-Market Surveillance (PMS) and PMCF data back into the CER. |
A compliant CER must demonstrate alignment with the General Safety and Performance Requirements (GSPR) outlined in Annex I of the MDR, establishing that the clinical benefits outweigh all identified residual risks.
4 Key Stages of the Clinical Evaluation Process
Preparing a Clinical Evaluation Report follows a structured four-stage lifecycle:
Stage 0: Scope & Planning (CEP)
The process begins with formulating a Clinical Evaluation Plan (CEP). The CEP specifies the device features, intended clinical purpose, target patient populations, specific clinical claims, and the state-of-the-art (SOTA) landscape in the relevant medical field.
Stage 1: Identification of Clinical Data
Manufacturers retrieve all pertinent clinical data from multiple sources, including:
Pre-market clinical investigations conducted on the specific device.
Scientific, peer-reviewed literature retrieved via systematic search protocols.
Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF) registries.
Clinical data derived from equivalent devices.
Stage 2: Data Appraisal
Each collected data set is evaluated for scientific validity, relevance, weighting, and quality using standardized appraisal criteria (such as MEDDEV 2.7/1 Rev 4 Appendix D).
Stage 3: Analysis & Conclusions
The appraised data is synthesized to assess GSPR conformity, risk-benefit acceptability, side-effect thresholds, and usability. The findings are documented in the final Clinical Evaluation Report.
Demonstrating Equivalence Under EU MDR Rules
Under EU MDR Article 61(5), manufacturers claiming equivalence to an existing CE-marked predicate device must satisfy stricter criteria than under the old MDD framework. Equivalence must be proven across three distinct categories:
| Equivalence Category | Mandatory Assessment Criteria |
| Technical Equivalence | Device design, operational principles, specifications, deployment conditions, and software algorithms. |
| Biological Equivalence | Materials or substances in contact with human tissues, contact duration, and release characteristics. |
| Clinical Equivalence | Clinical condition, severity, anatomical site, user population, and intended clinical effect. |
Note: For Class III and implantable devices, manufacturers must have a contract in place granting full access to the technical documentation of the equivalent device.
Special Considerations for Software & Wearables
Digital health devices—such as Software as a Medical Device (SaMD) and connected biosensors—present unique clinical evaluation challenges.
When evaluating innovative medical equipment like wearable medical devices, clinical evidence must address diagnostic algorithm accuracy, cybersecurity risks, sensor reliability, and usability in home healthcare settings. As wearable technology in healthcare rapidly advances, clinical evaluation reports for digital health must continuously integrate real-world performance data and software updates.
Talk to Operon Strategist’s Medical Device Experts Today
Need expert assistance structuring your EU MDR Clinical Evaluation Plan or CER?
Essential Components of a Technical File CER
A Notified Body-ready Clinical Evaluation Report must contain structured, audited sections:
Device Description & Intended Purpose: Models, variants, software versions, and clinical claims.
State of the Art (SOTA): Benchmark comparison of available medical/surgical alternatives and clinical standards.
Literature Search Strategy: Methodology, databases searched (e.g., PubMed, Embase), and inclusion/exclusion criteria.
Manufacturer Clinical Data: Bench testing, biocompatibility, risk management files (ISO 14971), and clinical trials.
PMS & PMCF Analysis: Real-world safety updates, incident reports, and customer feedback.
Risk-Benefit Evaluation: Justification that clinical benefits outweigh all identified risks.
Evaluator Qualifications: Curriculum Vitae (CV) and declarations of interest proving independent evaluator expertise.
CER Maintenance & Update Frequency
A Clinical Evaluation Report is a living document that requires active lifecycle maintenance linked to the manufacturer’s Post-Market Surveillance (PMS) system and Post-Market Clinical Follow-up (PMCF) evaluation reports.
| Mandatory CER Update Timelines | Requirements |
| Class III & Implantables | Updated at least ANNUALLY. |
| Class IIa & Class IIb | Updated every 2 to 5 YEARS (risk-based). |
| Class I | Updated as needed or upon significant market feedback. |
Additionally, any new post-market information (such as serious adverse events, field safety corrective actions, or design modifications) triggers an immediate off-cycle CER update.
How Operon Strategist Can Help
Operon Strategist specializes in guiding medical device manufacturers through the complexities of Clinical Evaluation Report (CER) creation, compliance, and ongoing lifecycle maintenance. Our regulatory experts provide end-to-end assistance to ensure your technical documentation meets stringent global standards:
Defining Device Scope: Assisting in clearly establishing device parameters, intended purpose, target patient populations, and clinical claims.
Validating Clinical Data: Identifying, gathering, and systematically appraising pre-market, literature, and clinical investigation data for safety and performance verification.
Analyzing Regulatory Compliance: Thoroughly evaluating device documentation to ensure 100% alignment with EU MDR Article 61, Annex XIV, and MEDDEV 2.7/1 Rev 4 guidelines.
Meeting Post-Market Surveillance (PMS) Needs: Structuring continuous PMS and Post-Market Clinical Follow-up (PMCF) workflows to keep your CER fully up to date as a living document.
Streamlining CE Marking Operations: Delivering audit-ready, robust CER dossiers that build reviewer confidence and accelerate your European CE Marking approval process.
Connect with Operon Strategist today to simplify your CER compliance strategy and secure market access with confidence.
Ensure Seamless Regulatory Compliance for Your Device
Get Your Medical Device Market-Ready with Expert Regulatory Support
FAQ's
What is a Clinical Evaluation Report (CER)?
A CER is a technical document that compiles clinical data to prove a medical device’s safety, performance, and risk-benefit ratio.
Is a CER required for all medical device risk classes in the EU?
Yes, under EU MDR 2017/745, a CER is mandatory for all medical device classes (Class I, IIa, IIb, and III).
How often must a CER be updated under EU MDR?
Class III and implantable devices require annual updates, while Class IIa and IIb devices are updated every 2 to 5 years.
Can you prove equivalence without access to technical files under EU MDR?
For Class III and implantable devices, a formal contract granting full access to the predicate’s technical file is required by law.
What guidelines govern CER preparation for European CE Marking?
CERs are governed by EU MDR Article 61, Annex XIV Part A, and the MEDDEV 2.7/1 Rev 4 guidance document.